Repository logo
 
Publication

Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema

2018-05Journal article Restricted access
Simple item page
dc.contributor.authorBusch, Catharina
dc.contributor.authorZur, Dinah
dc.contributor.authorFraser-Bell, Samantha
dc.contributor.authorLaíns, Inês
dc.contributor.authorSantos, Ana Rita
dc.contributor.authorLupidi, Marco
dc.contributor.authorCagini, Carlo
dc.contributor.authorGabrielle, Pierre-Henry
dc.contributor.authorCouturier, Aude
dc.contributor.authorMané-Tauty, Valérie
dc.contributor.authorGiancipoli, Ermete
dc.contributor.authorRicci, Giuseppe D'Amico
dc.contributor.authorCebeci, Zafer
dc.contributor.authorRodríguez-Valdés, Patricio J.
dc.contributor.authorChaikitmongkol, Voraporn
dc.contributor.authorAmphornphruet, Atchara
dc.contributor.authorHindi, Isaac
dc.contributor.authorAgrawal, Kushal
dc.contributor.authorChhablani, Jay
dc.contributor.authorLoewenstein, Anat
dc.contributor.authorIglicki, Matias
dc.contributor.authorRehak, Matus
dc.date.accessioned2021-02-08T16:09:38Z
dc.date.available2021-02-08T16:09:38Z
dc.date.issued2018-05
dc.description.abstractIn a real-world setting, eyes with DME considered refractory to anti-VEGF therapy after three monthly injections which were switched to DEX implant and had better visual and anatomical outcomes at 12 months than those that continued treatment with anti-VEGF therapy.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationBusch, C., Zur, D., Fraser-Bell, S. et al. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema. Acta Diabetol 55, 789–796 (2018). https://doi.org/10.1007/s00592-018-1151-xpt_PT
dc.identifier.doi10.1007/s00592-018-1151-xpt_PT
dc.identifier.urihttp://hdl.handle.net/10400.22/16923
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringerpt_PT
dc.relation.publisherversionhttps://link.springer.com/article/10.1007%2Fs00592-018-1151-x#citeaspt_PT
dc.subjectAnti-VEGF therapypt_PT
dc.subjectDexamethasonept_PT
dc.subjectMacular edemapt_PT
dc.titleShall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edemapt_PT
dc.typejournal article
dspace.entity.typePublication
person.familyNameSantos
person.givenNameAna Rita
person.identifier.ciencia-id0911-4138-0C3A
person.identifier.orcid0000-0003-0139-0285
rcaap.rightsclosedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationd71931b8-d869-4334-993c-ba14ad713f01
relation.isAuthorOfPublication.latestForDiscoveryd71931b8-d869-4334-993c-ba14ad713f01

Files

Collections

ESS - ORT - Artigos